In a recent study from Thailand, 18 girls with central precocious puberty were followed up under GnRH analogue treatment for 20 weeks, resulting in no change in serum ghrelin and PYY levels, but a significant increase in leptin levels along with fat percentage [14]. The gene discussed is GHRL; the disease is central precocious puberty.